Neoplasia/BPH

	Navigating work after prostate cancer treatment: a systematic review of qualitative research. J Cancer Surviv Tomic D, Keegel T, Schellack SK, Abdel-Malek L, Jander C, Hettige ST, MacFarlane E, Millar J, Walker-Bone K. PMID: 42303926 [PubMed - as supplied by publisher]
	A preoperative Artificial Intelligence model to estimate cancer-specific mortality in nonmetastatic kidney cancer patients. Nat Commun Larcher A, Traverso A, Scuri P, Capitanio U, Musso G, Canibus D, Barbieri S, Caivano L, Zambello A, Denti M, Campi R, Serni S, Granata S, Palmisano A, Vignale D, Montorsi F, Esposito A, Tacchetti C, Salonia A. PMID: 42303642 [PubMed - as supplied by publisher]
	Overall Survival of Patients With PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP DNA Vaccine Versus Placebo. Clin Genitourin Cancer McNeel DG, Eickhoff JC, Perez A, Liu G. PMID: 42303538 [PubMed - as supplied by publisher]
	Re: Final Overall Survival Results from EORTC 1333/PEACE-3 Trial of Enzalutamide plus Radium-223 in Metastatic Castration-resistant Prostate Cancer. Eur Urol Francini E. PMID: 42303526 [PubMed - as supplied by publisher]
	Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study. Eur Urol Mertens LS, Mellema JJ, Sridhar S, van der Heijden MS. PMID: 42303524 [PubMed - as supplied by publisher]
	Re: Pembrolizumab in Combination with Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial. Eur Urol Ma H, Zhou Q. PMID: 42303523 [PubMed - as supplied by publisher]
	Re: Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial. Eur Urol Yusuf S, Azam A, Sood I, Al-Sattar H, Mullassery V, Adeleke S. PMID: 42303522 [PubMed - as supplied by publisher]
	Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE Trials. Eur Urol Oncol Light A, Peters M, Gopalakrishnan A, Mayor N, Freeman A, Emberton M, Ahmed HU, Shah TT. PMID: 42303478 [PubMed - as supplied by publisher]
	Prevalence of homologous recombination repair genes alterations in metastatic castration-resistant prostate cancer, a multicentric study. Fr J Urol Allaume P, Raby M, Nourieh M, Lespagnol A, Tallet A, Péricart S, Tantot J, Lindner V, Decaussin M, Callens C, Descotes F, Allory Y, Rioux-Leclercq N, Kammerer-Jacquet SF, Fromont G. PMID: 42303208 [PubMed - as supplied by publisher]
	Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer. J Natl Compr Canc Netw Scilipoti P, de Angelis M, Thibault C, , Del Giudice F, Contieri R, Hurle R, Subiela JD, Simone G, Proietti F, Mori K, Shariat S, D'Andrea D, Zamboni S, Suardi N, Tanaka H, Matsumoto S, Fujii Y, Bertolo R, Antonelli A, Diamant E, Vordos D, Gabriel PE, Harber T, Colombel M, Hanquiez P, Chatain V, Duquesne I, Borz MB, Verhoest G, Mauger De Varennes A, Surlemont L, Ghenassia M, Masson-Lecomte A, Peyrottes A, Lebacle C, Beniac P, Léon P, Larré S, Taha F, Marcq G, Szostek A, Pradere B, Calleris G, Audenet F, Xylinas E, Allory Y, Bajeot AS, Prost D, Grobet-Jeandin E, Montorsi F, Necchi A, Briganti A, Moschini M, Roumiguié M, Rouprêt M, Seisen T. PMID: 42302838 [PubMed - as supplied by publisher]
	Hepatic Inflammatory Pseudotumor Presenting as FDG-avid Liver Lesions in a Prostate Cancer Patient: A Diagnostic Pitfall on PET/CT. Clin Nucl Med Weng Y, Yin H, Shi H. PMID: 42302736 [PubMed - as supplied by publisher]
	Multiplex biomarker detection platform based on zinc protoporphyrin-modified gold electrodes: Application potential for early diagnosis and postoperative monitoring of prostate cancer. Biosens Bioelectron Lin HY, Liao CC, Tsai SH, Yu KJ, Hua MY. PMID: 42302329 [PubMed - as supplied by publisher]
	Machine-learning-assisted artificial olfactory colorimetric sensor array for bladder cancer early detection from urinary volatile organic compounds. Biosens Bioelectron Xiong Y, Xiao J, Jing L, Bian Y, Liao L, Hou Z, Xia GJ, Yu A, Niu Y. PMID: 42302328 [PubMed - as supplied by publisher]
	Navigating Uncertainty in MRI Diagnosis: A Human-AI Collaborative Strategy for Stratifying Clinically Significant Prostate Cancer. J Magn Reson Imaging Fu X, Bao J, Qiao X, Shen J, Zhang Y, Jin P, Ji Y, Zhang J, Su Y, Ji L, Li Z, Wang X, Shen H, Hu C, Liu J. PMID: 42302213 [PubMed - as supplied by publisher]
	Immunohistochemistry for p16 and p53 Provides Substantial Agreement With Molecular Tests in Penile Cancer. Pathol Int Hrudka J, Hojný J, Krkavcová E, Dvo, Prouzová Z, Bárt, Zavillová N, , Mat, Waldauf P. PMID: 42302123 [PubMed - indexed for MEDLINE]
	AI in Prostate Cancer Screening & Diagnosis: A Registry-Based Study of ClinicalTrials.gov Trials. Inquiry Hareeri RH, Aldurdunji MM. PMID: 42301955 [PubMed - indexed for MEDLINE]
	Unveiling the rare, interesting series of malignant mesenchymal tumors of the kidney in a regional cancer care institute in South India. Indian J Cancer Hemavathi N, Patil Okaly GV, Suma MN, Champaka G, Ashwini N, Priya D. PMID: 42301664 [PubMed - indexed for MEDLINE]
	PI-RADS v2 score may be as a predictor of bone metastasis in prostate cancer. Indian J Cancer Liu T, Zhu CH, Yang K, Du Y, Cheng F. PMID: 42301661 [PubMed - indexed for MEDLINE]
	Long-term outcomes of upper tract urothelial carcinoma in kidney transplant recipients: efficacy of bilateral radical nephroureterectomy and prognostic comparison of unilateral nephroureterectomy with non-transplant patients. World J Urol Yang X, Zhang Q, Ma L, Zhang S, Hou X. PMID: 42301343 [PubMed - indexed for MEDLINE]
	Urease-coated polydopamine nanomotors as self-propelled biosensors for non-invasive diagnosis: detection of prostate cancer-associated miR-141 in urine. Anal Methods Özcan Özseven S, Yurdabak Karaca G, Öksüz L, Wang J, Uygun Öksüz A. PMID: 42301183 [PubMed - as supplied by publisher]

Articles 1 - 20 / 188690

Page 1 of 9435



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy